Aytu Biopharma (AYTU) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Aytu Biopharma (AYTU) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.56% |
| Dec 31, 2025 | 22.93% |
| Sep 30, 2025 | -9.91% |
| Jun 30, 2025 | 75.66% |
| Mar 31, 2025 | 33.05% |
| Dec 31, 2024 | 66.22% |
| Sep 30, 2024 | 35.29% |
| Jun 30, 2024 | 78.48% |
| Dec 31, 2023 | 26.34% |
| Sep 30, 2023 | 82.20% |
| Jun 30, 2023 | 96.72% |
| Mar 31, 2023 | 82.96% |
| Dec 31, 2022 | 73.46% |
| Sep 30, 2022 | 86.88% |
| Mar 31, 2022 | 60.45% |
| Dec 31, 2021 | 63.16% |
| Sep 30, 2021 | 75.12% |
| Jun 30, 2021 | -186.72% |
| Dec 31, 2020 | -23.17% |
| Sep 30, 2020 | 41.03% |